175 related articles for article (PubMed ID: 37155147)
1. Genistein exerts anti-colorectal cancer actions: clinical reports, computational and validated findings.
Liu X; Lan Y; Zhang L; Ye X; Shen Q; Mo G; Chen X
Aging (Albany NY); 2023 May; 15(9):3678-3689. PubMed ID: 37155147
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein.
Chen X; Gu J; Wu Y; Liang P; Shen M; Xi J; Qin J
Biomed Pharmacother; 2020 Apr; 124():109835. PubMed ID: 31958764
[TBL] [Abstract][Full Text] [Related]
3. Systematic and experimental investigations of the anti-colorectal cancer mediated by genistein.
Zhang L; Zhang J; Gong Y; Lv L
Biofactors; 2020 Nov; 46(6):974-982. PubMed ID: 32951326
[TBL] [Abstract][Full Text] [Related]
4. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer.
Chen X; Wu Y; Gu J; Liang P; Shen M; Xi J; Qin J
Biofactors; 2020 Jul; 46(4):620-628. PubMed ID: 32078221
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and
Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-related biotargets and network mechanisms of fucoidan against colorectal cancer: An integrated bioinformatic and experimental approach.
Liu J; Meng Y; Li B; Wang P; Wan X; Huang W; Li R
Int J Biol Macromol; 2022 Dec; 222(Pt A):1522-1530. PubMed ID: 36195230
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
9. Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study.
Dai W; Yang J; Liu X; Mei Q; Peng W; Hu X
BMC Complement Med Ther; 2023 Jan; 23(1):4. PubMed ID: 36624500
[TBL] [Abstract][Full Text] [Related]
10. Targeting STAT proteins via computational analysis in colorectal cancer.
Dariya B; Muppala S; Srivani G; Momin S; Alam A; Saddala MS
Mol Cell Biochem; 2021 Jan; 476(1):165-174. PubMed ID: 32840738
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
13. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
14. Investigating the effects and mechanisms of Erchen Decoction in the treatment of colorectal cancer by network pharmacology and experimental validation.
Shao Y; Chen J; Hu Y; Wu Y; Zeng H; Lin S; Lai Q; Fan X; Zhou X; Zheng M; Gao B; Sun J
Front Pharmacol; 2022; 13():1000639. PubMed ID: 36313338
[No Abstract] [Full Text] [Related]
15. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.
Shang L; Wang Y; Li J; Zhou F; Xiao K; Liu Y; Zhang M; Wang S; Yang S
J Ethnopharmacol; 2023 Feb; 302(Pt A):115876. PubMed ID: 36343798
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo.
Zhu H; Cheng H; Ren Y; Liu ZG; Zhang YF; De Luo B
Mol Biol Rep; 2012 Apr; 39(4):4971-9. PubMed ID: 22160570
[TBL] [Abstract][Full Text] [Related]
18. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanism of resveratrol combined with irinotecan in treatment of colorectal cancer].
Li F; Yan RY; Li KY; Wang J; Wang L; Shen H; Han CL; Liu M
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2212-2221. PubMed ID: 37282909
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]